Zomedica Corp. (ZOMDF): Total Liabilities
$11.64M
As of 2025-12-31
$10.86M
As of 2026-06-30
-1.6%
3-year compound annual growth
+30.2%
5-year compound annual growth
| Period ended | Total Liabilities | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $11.64M | -0.5% | 2026-03-16, Balance as of period end |
| 2024-12-31 | $11.70M | -11.3% | 2026-03-16, Balance as of period end |
| 2023-12-31 | $13.18M | +7.9% | 2025-03-13, Balance as of period end |
| 2022-12-31 | $12.22M | +28.4% | 2024-04-01, Balance as of period end |
| 2021-12-31 | $9.51M | +205.2% | 2023-03-15, Balance as of period end |
| 2020-12-31 | $3.12M | +49.3% | 2022-03-01, Balance as of period end |
| 2019-12-31 | $2.09M | n/a | 2021-02-26, Balance as of period end |
Total Liabilities at similar companies
| Company | Year ended | Total Liabilities | Change YoY |
|---|---|---|---|
| Zomedica Corp. (ZOMDF) | 2025-12-31 | $11.64M | -0.5% |
| Verastem, Inc. (VSTM) | 2025-12-31 | $189.25M | +45.1% |
| Foghorn Therapeutics Inc. (FHTX) | 2025-12-31 | $306.60M | -7.0% |
| Verrica Pharmaceuticals Inc. (VRCA) | 2025-12-31 | $22.39M | -65.0% |
| Earth Science Tech, Inc. (ETST) | 2026-03-31 | $1.93M | -40.0% |
| Sunshine Biopharma Inc. (SBFM) | 2025-12-31 | $7.04M | -0.3% |
| Lftd Partners Inc. (LIFD) | 2025-12-31 | $6.64M | -34.4% |
| Cue Biopharma, Inc. (CUE) | 2025-12-31 | $15.78M | +7.4% |
| BGM Group Ltd. (BGM) | 2025-09-30 | $41.92M | +370.4% |
Compare ZOMDF, VSTM, FHTX, VRCA side by side · Screen every company in Pharmaceutical Preparations ↗